Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Nemolizumab-ilto bulk supplier for pharma manufacturers

Nemolizumab-Ilto 30 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 30 mg/mL

Reference Brands: Nemluvio (USA)

Category: Derma Drugs

Nemolizumab-Ilto is a Derma Drugs product available as Injection in strengths 30 mg/mL. It corresponds to the reference brand Nemluvio (USA). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Nemolizumab-ilto injection is a biologic medicine used for the treatment of moderate to severe inflammatory skin conditions. It is administered alone or in combination with other treatments such as topical corticosteroids or calcineurin inhibitors when symptoms are not adequately controlled with topical therapy alone. This targeted treatment option is especially beneficial for patients who continue to experience persistent symptoms despite standard topical management.

Nemolizumab-ilto is also indicated for the treatment of prurigo nodularis, a chronic skin disorder characterized by intense itching and nodular skin lesions. By targeting specific immune pathways involved in itch and inflammation, nemolizumab-ilto helps reduce pruritus and improve skin condition. Its mechanism of action addresses the underlying causes of itch and inflammation rather than only providing symptomatic relief.

Nemolizumab-Ilto — third party manufacturing & bulk supply

Nemolizumab-Ilto 30 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Nemolizumab-Ilto listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Nemolizumab-Ilto →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Nemolizumab-ilto is used for the treatment of prurigo nodularis in adults.

Nemolizumab-ilto is a recombinant humanized monoclonal antibody produced using biotechnology and genetic engineering techniques.

The trade name of nemolizumab-ilto is Nemluvio.

Nemluvio is developed and marketed by Galderma.

The generic name is nemolizumab-ilto.

The brand name is Nemluvio.

Nemolizumab-ilto is manufactured in specialized biologics manufacturing facilities, primarily in the United States and Europe, depending on the supply region.

Related Products

Sofpironium Bromide

Strength:
5%, 12.45%

Form: Topical Gel

Reference Brands: ECCLOCK, Sofdra

View Details
Sarecycline

Strength:
60 mg, 100 mg, 150 mg

Form: Tablets

Reference Brands: Seysara (USA)

View Details
Afamelanotide

Strength:
16 mg

Form: Subcutaneous implant

Reference Brands: Scenesse (USA)

View Details
Glycopyrronium Tosylate

Strength:
2.4%

Form:

Reference Brands: Qbrexza (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.